Tag: cytori therapeutics
October 30, 2018
Cytori Therapeutics Announces Receipt of Puregraft Royalty Milestone
Cytori Therapeutics (Nasdaq:CYTX) announced today it has received a milestone payment of $1.0 million from Bimini Technologies. The payment is a... August 15, 2018
Cytori Reports Q2 2018 Business and Financial Results
Cytori Therapeutics (NASDAQ:CYTX) announced Q2 2018 financial results and provided updates on corporate activities. As quoted in the press release: Q2... April 30, 2018
Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin
Cytori Therapeutics (Nasdaq:CYTX) provided an update on its plans for US manufacturing and EU approval for its ATI-0918 liposomal doxorubicin product.... March 29, 2018
Enrollment Completed in ADRESU Clinical Trial of Cytori Cell Therapy for Stress Urinary Incontinence
Cytori Therapeutics (NASDAQ:CYTX) announced that full enrollment has been reached in the ADRESU investigator-initiated clinical trial of Cytori Cell Therapy... March 9, 2018
Cytori Reports Fourth Quarter and Full Year 2017 Business and Financial Results
Cytori Therapeutics (NASDAQ:CYTX) announced its fourth quarter and year-end 2017 financial results and provided updates on its corporate activity and clinical... April 10, 2017
Cytori Gets Green Light for Thermal Burn Clinical Trial
Cytori Therapeutics received approval from the US Food and Drug Administration for a burn clinical trial using the Cytori Cell... April 10, 2017